Sulforadex in Healthy Human Males MAD
To determine the safety and tolerability of multiple doses of Sulforadex® in healthy male volunteers over 7 days with qd or bid dosing
Prostate Cancer
DRUG: Sulforadex|DRUG: alpha-cyclodextrin
Number of participants with adverse events, Safety assessments will include standard laboratory safety tests (haematology, biochemistry, coagulation and urinalysis), vital signs, physical examinations, 12-lead ECG, telemetry and AE monitoring., 7 days
Area under the plasma concentration versus time curve (AUC) of sulforaphane, Plasma sulforaphane concentrations will be measured by LCMS/MS assay.

• Area under the plasma concentration-time curve from zero to time t of the last measured concentration above the limit of quantification (AUC0-t)., time 0, 30 min 1 2 4 8 12 & 24 hrs post dose on days 1,2 & 7
This study will be conducted in a randomised, double-blind, placebo-controlled design with multiple ascending doses of Sulforadex® administered qd \[once daily\] or bid \[twice daily\]) to healthy male subjects between 18 to 45 years of age.